|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets | |||||||||||||||
| Cash | |||||||||||||||
| Tax receivable | |||||||||||||||
| Prepaid expenses | |||||||||||||||
| Total current assets | |||||||||||||||
| Securities held-to-maturity in Trust Account, at amortized cost | |||||||||||||||
| Investments held in Trust Account | |||||||||||||||
| Common Class A | |||||||||||||||
| Total investments held in Trust Account | |||||||||||||||
| Total assets | |||||||||||||||
| Current liabilities | |||||||||||||||
| Accrued expenses | |||||||||||||||
| Accounts payable | |||||||||||||||
| Deferred tax liability | |||||||||||||||
| Accounts payable and accrued expenses | |||||||||||||||
| Excise tax payable | |||||||||||||||
| Income taxes payable | |||||||||||||||
| Convertible promissory note – related party, at fair value | |||||||||||||||
| Reserve for uncertain tax positions | |||||||||||||||
| Franchise tax payable | |||||||||||||||
| Non-Redemption Agreement | |||||||||||||||
| Derivative warrant liability | |||||||||||||||
| Note payable – Sponsor | |||||||||||||||
| Note Payable - Polar, at fair value | |||||||||||||||
| Due to related party | |||||||||||||||
| Total current liabilities | |||||||||||||||
| Deferred underwriting fee payable | |||||||||||||||
| Reserve for uncertain tax positions - long-term | |||||||||||||||
| Total liabilities | |||||||||||||||
| Class A common stock, $0.0001 par value; 200,000,000 shares authorized; 1,212,124 shares issued and outstanding at approximately $10.98 and $10.95 redemption value at March 31, 2025 and December 31, 2024, respectively | |||||||||||||||
| Common Class A | |||||||||||||||
| Total class A common stock, $0.0001 par value; 200,000,000 shares authorized; 1,212,124 shares issued and outstanding at approximately $10.98 and $10.95 redemption value at March 31, 2025 and December 31, 2024, respectively | |||||||||||||||
| Stockholders’ deficit | |||||||||||||||
| Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none outstanding | |||||||||||||||
| Common stock | |||||||||||||||
| Common Class A | |||||||||||||||
| Common Class B | |||||||||||||||
| Accumulated deficit | |||||||||||||||
| Total stockholders’ deficit | |||||||||||||||
| Total liabilities, temporary equity and stockholders’ deficit | |||||||||||||||
Loading...
